Pharmacogenetic drug interaction management system
US10262107B1 · kind B1 · utility
7Cited by
0References
20Claims
0Family size
Inventors
Key dates
| Filing date | Apr 4, 2016 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Apr 4, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06N7/01
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
A system includes a substance to be consumed by a subject and one or more indicia labeling the substance with: genomic biomarkers; drug exposure and clinical response variability; risk for adverse events; genotype-specific dosing; polymorphic drug target and disposition genes; and treatment based on the biomarker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.